Analysts Expect Daseke Inc (NASDAQ:DSKE) Will Post Earnings of -$0.17 Per Share

Share on StockTwits

Equities analysts predict that Daseke Inc (NASDAQ:DSKE) will announce ($0.17) earnings per share (EPS) for the current fiscal quarter, according to Zacks. Three analysts have issued estimates for Daseke’s earnings, with estimates ranging from ($0.29) to ($0.10). Daseke posted earnings of $0.02 per share during the same quarter last year, which indicates a negative year-over-year growth rate of 950%. The company is scheduled to announce its next earnings results on Tuesday, November 5th.

According to Zacks, analysts expect that Daseke will report full-year earnings of ($0.60) per share for the current fiscal year, with EPS estimates ranging from ($0.85) to ($0.31). For the next year, analysts expect that the business will post earnings of ($0.49) per share, with EPS estimates ranging from ($0.66) to ($0.34). Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side analysts that follow Daseke.

Daseke (NASDAQ:DSKE) last announced its quarterly earnings results on Monday, August 5th. The company reported ($0.12) earnings per share for the quarter, missing the consensus estimate of ($0.07) by ($0.05). The company had revenue of $450.60 million for the quarter, compared to analyst estimates of $459.30 million. Daseke had a positive return on equity of 0.39% and a negative net margin of 1.87%. Daseke’s revenue for the quarter was up 19.6% on a year-over-year basis. During the same period in the prior year, the business posted $0.20 earnings per share.

Several brokerages have weighed in on DSKE. Craig Hallum downgraded Daseke from a “buy” rating to a “hold” rating in a research report on Monday, August 5th. Zacks Investment Research downgraded Daseke from a “hold” rating to a “strong sell” rating in a research report on Monday, June 24th. BidaskClub downgraded Daseke from a “hold” rating to a “sell” rating in a research report on Friday, June 21st. Finally, ValuEngine raised Daseke from a “hold” rating to a “buy” rating in a research report on Friday, August 16th. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the company’s stock. Daseke has an average rating of “Hold” and an average target price of $7.50.

DSKE traded up $0.09 during midday trading on Friday, hitting $2.97. 474,728 shares of the company were exchanged, compared to its average volume of 456,967. The company’s 50 day simple moving average is $2.32 and its 200 day simple moving average is $3.97. The firm has a market capitalization of $192.46 million, a price-to-earnings ratio of 4.64 and a beta of 1.38. The company has a current ratio of 1.41, a quick ratio of 1.41 and a debt-to-equity ratio of 1.74. Daseke has a 1-year low of $1.46 and a 1-year high of $8.81.

In other news, Director Ena Williams purchased 22,000 shares of the business’s stock in a transaction dated Friday, September 13th. The stock was acquired at an average price of $3.36 per share, for a total transaction of $73,920.00. Also, COO Christopher R. Easter purchased 20,000 shares of the business’s stock in a transaction dated Wednesday, August 7th. The shares were purchased at an average price of $2.17 per share, with a total value of $43,400.00. The disclosure for this purchase can be found here. Over the last three months, insiders have bought 57,000 shares of company stock worth $151,070. Corporate insiders own 29.71% of the company’s stock.

Institutional investors and hedge funds have recently made changes to their positions in the stock. BNP Paribas Arbitrage SA lifted its holdings in shares of Daseke by 447.9% in the first quarter. BNP Paribas Arbitrage SA now owns 8,537 shares of the company’s stock valued at $43,000 after purchasing an additional 6,979 shares in the last quarter. Public Employees Retirement System of Ohio boosted its stake in Daseke by 101.8% during the 2nd quarter. Public Employees Retirement System of Ohio now owns 11,579 shares of the company’s stock valued at $42,000 after acquiring an additional 5,842 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Daseke by 278.5% during the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 14,489 shares of the company’s stock valued at $74,000 after acquiring an additional 10,661 shares during the last quarter. SG Americas Securities LLC bought a new position in shares of Daseke in the 1st quarter worth about $75,000. Finally, Jane Street Group LLC acquired a new stake in shares of Daseke in the 2nd quarter worth about $57,000. 31.58% of the stock is owned by hedge funds and other institutional investors.

Daseke Company Profile

Daseke, Inc provides transportation and logistics solutions with a focus on flatbed and specialized freight in North America. It operates through two segments, Flatbed Solutions and Specialized Solutions. The company transports aircraft parts, manufacturing equipment, structural steel, pressure vessels, wind turbine blades, heavy machinery, commercial glass, high security cargo, arms, ammunition and explosives, lumber, and building and construction materials.

See Also: Are FAANG stocks a good investment?

Get a free copy of the Zacks research report on Daseke (DSKE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Daseke (NASDAQ:DSKE)

Receive News & Ratings for Daseke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daseke and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Investment Analysts’ Price Target Changes for October, 14th
Investment Analysts’ Price Target Changes for October, 14th
Civic  Market Cap Achieves $26.92 Million
Civic Market Cap Achieves $26.92 Million
TRAXIA Tops 24-Hour Trading Volume of $207.00
TRAXIA Tops 24-Hour Trading Volume of $207.00
TOP  Price Hits $0.0022
TOP Price Hits $0.0022
Syndax Pharmaceuticals  Stock Rating Upgraded by Zacks Investment Research
Syndax Pharmaceuticals Stock Rating Upgraded by Zacks Investment Research
Laboratory Corp. of America  Stock Rating Upgraded by Zacks Investment Research
Laboratory Corp. of America Stock Rating Upgraded by Zacks Investment Research


 
© 2006-2019 Zolmax.